Absci (ABSI) Other Non-Current Liabilities (2020 - 2026)
Absci's (ABSI) quarterly Other Non-Current Liabilities came in at $806000.0 in Q1 2026, down 52.17% year-on-year from $1.7 million in Q1 2025, and down 21.21% quarter-over-quarter from $1.0 million in Q4 2025.
Absci (ABSI) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends
Absci has disclosed Other Non-Current Liabilities across 7 years of filings, most recently posting $806000.0 for Q1 2026.
- Other Non-Current Liabilities for Q1 2026 came in at $806000.0, down 52.17% year-over-year; the trailing twelve-month figure through Mar 2026 was $806000.0 (down 52.17% YoY), and the FY2025 annual result was $1.0 million, up 669.17% from the prior year.
- Other Non-Current Liabilities came in at $806000.0 for Q1 2026 at Absci, down from $1.0 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $1.8 million in Q3 2025 to a low of $15000.0 in Q2 2024.
- The 5-year median for Other Non-Current Liabilities is $224500.0 (2022), against an average of $560785.7.
- Across the five-year window, Other Non-Current Liabilities tumbled 99.73% in 2022 and jumped 9780.0% in 2025, its largest moves.
- Absci's Other Non-Current Liabilities stood at $35000.0 in 2022, then jumped by 742.86% to $295000.0 in 2023, then slumped by 54.92% to $133000.0 in 2024, then soared by 669.17% to $1.0 million in 2025, then retreated by 21.21% to $806000.0 in 2026.
- The last three Other Non-Current Liabilities figures came in at $806000.0 (Q1 2026), $1.0 million (Q4 2025), and $1.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Absci | 1.13 Bn | 1.01 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 806,000.00 |
| Dec 31, 2025 | 1.02 Mn |
| Sep 30, 2025 | 1.79 Mn |
| Jun 30, 2025 | 1.48 Mn |
| Mar 31, 2025 | 1.69 Mn |
| Dec 31, 2024 | 133,000.00 |
| Sep 30, 2024 | 31,000.00 |
| Jun 30, 2024 | 15,000.00 |
| Mar 31, 2024 | 78,000.00 |
| Dec 31, 2023 | 295,000.00 |
| Dec 31, 2022 | 35,000.00 |
| Sep 30, 2022 | 33,000.00 |
| Jun 30, 2022 | 227,000.00 |
| Mar 31, 2022 | 222,000.00 |
| Dec 31, 2021 | 12.16 Mn |
| Sep 30, 2021 | 12.13 Mn |
| Jun 30, 2021 | 15.00 Mn |
| Dec 31, 2020 | 749,000.00 |